Pediatrics Division, Shamir (Assaf Harofeh) Medical Center, Zerifin, affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Clinical Pharmacology and Toxicology Unit, Shamir (Assaf Harofeh) Medical Center, Zerifin, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Reprod Toxicol. 2024 Sep;128:108658. doi: 10.1016/j.reprotox.2024.108658. Epub 2024 Jul 6.
This study aimed to evaluate associations between prenatal and childhood exposure to phthalates and prenatal exposure to polychlorinated biphenyls (PCBs) and the development of 4-year-old children. Urinary metabolites of five phthalates were measured in women upon delivery, as well as serum concentrations of four PCB congeners. Postnatal phthalate metabolites were measured from children's urine obtained at the time of developmental assessment. The primary outcome was cognitive function as evaluated by the Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III) administered at 4 years. Secondary outcomes were motor function and response to sensory stimuli as evaluated by the Developmental Coordination Disorder Questionnaire (DCDQ) and Short Sensory Profile (SSP) that the mothers filled out, respectively. The study included 57 mother-child pairs. Higher maternal phthalate metabolite concentrations were inversely associated with WPPSI-III scores among boys and not among girls. After using linear regression models and controlling for confounding variables, we found that higher levels of monobenzyl phthalate (MBzP) were the ones associated with lower WPPSI-III scores (p=0.004, 95 %CI [-14.18; -3.16]), lower DCDQ scores (p=0.007, 95 %CI [-6.08; -1.17] and lower SSP scores (p=0.004, 95 %CI [-7.47; -1.79]). No association was found between child urinary phthalate metabolite concentrations or maternal PCB blood concentrations and developmental function. These findings indicate that higher prenatal phthalate metabolite levels may be associated with deficits in neurologic development of young boys.
本研究旨在评估产前和儿童时期接触邻苯二甲酸酯和多氯联苯(PCBs)与 4 岁儿童发育之间的关联。在分娩时测量女性尿液中 5 种邻苯二甲酸酯的代谢物,以及血清中 4 种 PCB 同系物的浓度。在发育评估时,从儿童尿液中测量出生后的邻苯二甲酸酯代谢物。主要结局是通过韦氏学前和小学智力量表(WPPSI-III)评估的认知功能,该量表在 4 岁时进行评估。次要结局是通过发育协调障碍问卷(DCDQ)和母亲分别填写的短感觉量表(SSP)评估的运动功能和对感觉刺激的反应。该研究包括 57 对母婴。较高的母体邻苯二甲酸酯代谢物浓度与男孩的 WPPSI-III 评分呈负相关,而与女孩的 WPPSI-III 评分无关。在使用线性回归模型并控制混杂变量后,我们发现较高的单苄基邻苯二甲酸酯(MBzP)水平与 WPPSI-III 评分较低(p=0.004,95%CI [-14.18; -3.16])、DCDQ 评分较低(p=0.007,95%CI [-6.08; -1.17])和 SSP 评分较低(p=0.004,95%CI [-7.47; -1.79])有关。儿童尿液中邻苯二甲酸酯代谢物浓度或母体 PCB 血浓度与发育功能之间没有关联。这些发现表明,较高的产前邻苯二甲酸酯代谢物水平可能与小男孩神经发育缺陷有关。